ROCKVILLE, Md. (WJZ) — The U.S. Food and Drug Administration has approved a Maryland company’s potential HIV cure for human trials, the company announced this week.
Rockville-based American Gene Technologies said in a news release it will begin its phase one study at sites in the Baltimore and Washington, D.C. areas.READ MORE: More Violence In Fells Point: Business Owners Believe Concerns Continue To Go Unanswered Police: 3 Month Old Baby Dies After Being Found Unresponsive In West Baltimore Home
In November 2019, the company said its single-dose gene therapy has a “high potential” of being effective, describing the treatment as a genetically-modified product made from a person’s own cells that focuses on repairing immune system damage caused by the virus.MORE NEWS: 4 Teens Arrested & Charged Following A Vaping Incident On Ocean City Boardwalk
The trial is set to begin next month, and the company hopes to report initial data by the end of 2020.